IDEAYA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	298.93	84.38	157.02	68.63	92.05	72.04
Short-Term Investments	487.97	591.94	368.1	296.2	154.72	211.55
Cash & Short-Term Investments	786.89	676.32	525.11	364.83	246.77	283.59
Cash Growth	-14.47%	28.79%	43.93%	47.84%	-12.98%	186.58%
Receivables	-	0	0.02	0.21	1.1	1.88
Prepaid Expenses	15.76	13.39	7.5	5.41	3.12	3.14
Total Current Assets	802.66	689.71	532.63	370.45	251	288.61
Property, Plant & Equipment	31.72	27.74	8.41	8.99	8.66	9.48
Long-Term Investments	349.96	405.83	107.49	8.32	121.29	-
Other Long-Term Assets	0.81	0.81	0.78	0.21	0.4	0.19
Total Assets	1,185	1,124	649.32	387.97	381.35	298.27
Accounts Payable	18.43	15.42	6.6	4.28	2.1	0.95
Accrued Expenses	45.26	30.35	18.76	17	12.32	8.52
Current Portion of Leases	0.33	0.3	1.75	1.87	1.7	1.54
Current Unearned Revenue	0.49	-	-	8.57	29.04	27.61
Other Current Liabilities	-	-	-	-	-	0.02
Total Current Liabilities	64.51	46.07	27.1	31.72	45.16	38.64
Long-Term Leases	26.92	18.87	1.13	1.61	3.48	5.18
Long-Term Unearned Revenue	1.68	-	-	5.19	31.19	56.16
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	93.1	64.94	28.23	38.51	79.83	100
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,743	1,681	968.89	587.72	478.97	325.25
Retained Earnings	-653.27	-622.84	-348.36	-235.4	-176.75	-126.99
Comprehensive Income & Other	2.05	0.81	0.56	-2.87	-0.71	0.01
Total Common Equity	1,092	1,059	621.09	349.46	301.51	198.27
Shareholders' Equity	1,092	1,059	621.09	349.46	301.51	198.27
Total Liabilities & Equity	1,185	1,124	649.32	387.97	381.35	298.27
Total Debt	27.25	19.17	2.87	3.48	5.18	6.72
Net Cash (Debt)	1,110	1,063	629.73	369.66	362.88	276.86
Net Cash Growth	-6.07%	68.80%	70.35%	1.87%	31.07%	195.45%
Net Cash Per Share	12.58	13.01	10.95	8.92	10.29	11.20
Filing Date Shares Outstanding	87.67	87.54	74.56	48.39	38.63	32.25
Total Common Shares Outstanding	87.67	86.5	65.04	48.19	38.53	29.52
Working Capital	738.15	643.64	505.53	338.74	205.84	249.97
Book Value Per Share	12.46	12.24	9.55	7.25	7.82	6.72
Tangible Book Value	1,092	1,059	621.09	349.46	301.51	198.27
Tangible Book Value Per Share	12.46	12.24	9.55	7.25	7.82	6.72
Machinery	16.66	15.53	12.22	10.51	7.02	5.33
Leasehold Improvements	4.94	4.91	3.32	3.32	3.13	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.